Aytu Current Deferred Revenue from 2010 to 2024
| AYTU Stock | USD 1.62 0.02 1.25% |
Current Deferred Revenue | First Reported 2007-12-31 | Previous Quarter 43.4 M | Current Value 38.6 M | Quarterly Volatility 22.2 M |
Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 4.6 M or Selling General Administrative of 12.1 M, as well as many indicators such as Price To Sales Ratio of 304, Dividend Yield of 0.0 or PTB Ratio of 3.34. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
Aytu | Current Deferred Revenue |
Latest Aytu BioScience's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Aytu BioScience over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Aytu BioScience's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Aytu Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 15,339,088 | |
| Geometric Mean | 1,358,819 | |
| Coefficient Of Variation | 150.51 | |
| Mean Deviation | 20,097,367 | |
| Median | 339,336 | |
| Standard Deviation | 23,086,734 | |
| Sample Variance | 533T | |
| Range | 57.1M | |
| R-Value | 0.73 | |
| Mean Square Error | 268.9T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | 3,763,624 | |
| Total Sum of Squares | 7462T |
Aytu Current Deferred Revenue History
About Aytu BioScience Financial Statements
Aytu BioScience shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 38.6 M | 27.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.